FDA Investigating Potential Sex Differences in LAAO Adverse Outcomes FDA Investigating Potential Sex Differences in LAAO Adverse Outcomes

The agency flagged healthcare providers on recently reported data that showed higher rates of adverse events in women than in men undergoing implantation of a LAAO device.Medscape Medical News

Source: Medscape Cardiology Headlines - September 27, 2021 Category: Cardiology Tags: Cardiology News Source Type: news